O

Oscotec Inc
KOSDAQ:039200

Watchlist Manager
Oscotec Inc
KOSDAQ:039200
Watchlist
Price: 24 050 KRW -1.64% Market Closed
Market Cap: 919.8B KRW
Have any thoughts about
Oscotec Inc?
Write Note

Relative Value

The Relative Value of one Oscotec Inc stock under the Base Case scenario is 6 483.04 KRW. Compared to the current market price of 24 050 KRW, Oscotec Inc is Overvalued by 73%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6 483.04 KRW
Overvaluation 73%
Relative Value
Price
O
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
20
vs Industry
2
Median 3Y
178.9
Median 5Y
130.7
Industry
2.5
Forward
27
vs History
vs Industry
Median 3Y
-37.6
Median 5Y
-43.5
Industry
21.9
Forward
-193.1
vs History
vs Industry
Median 3Y
-42.8
Median 5Y
-42.8
Industry
16.5
vs History
vs Industry
Median 3Y
-41
Median 5Y
-48.6
Industry
23.6
vs History
74
vs Industry
3
Median 3Y
12.5
Median 5Y
14.2
Industry
2.1
vs History
23
vs Industry
2
Median 3Y
168.7
Median 5Y
124.8
Industry
2.6
Forward
24.5
vs History
23
vs Industry
1
Median 3Y
268.5
Median 5Y
217.1
Industry
5.2
vs History
vs Industry
Median 3Y
-32.2
Median 5Y
-32.6
Industry
13.3
Forward
-174.5
vs History
vs Industry
Median 3Y
-30.3
Median 5Y
-31.4
Industry
16.6
Forward
-131.3
vs History
vs Industry
Median 3Y
-38.7
Median 5Y
-38.7
Industry
15.6
vs History
vs Industry
Median 3Y
-36.9
Median 5Y
-39.7
Industry
19.1
vs History
33
vs Industry
3
Median 3Y
24.5
Median 5Y
24.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Oscotec Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Oscotec Inc
KOSDAQ:039200
913.8B KRW 197.9 -34.7 -26.2 -24.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average P/E: 32.4
Negative Multiple: -34.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top